- Home
- CALC vs BATL Comparison
CALC vs BATL Comparison
Compare CALC & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- BATL
- Stock Information
- Founded
- CALC 2011
- BATL 1987
- Country
- CALC United States
- BATL United States
- Employees
- CALC N/A
- BATL N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- BATL Oil & Gas Production
- Sector
- CALC Health Care
- BATL Energy
- Exchange
- CALC Nasdaq
- BATL Nasdaq
- Market Cap
- CALC 20.9M
- BATL 20.6M
- IPO Year
- CALC N/A
- BATL N/A
- Fundamental
- Price
- CALC $2.01
- BATL $1.30
- Analyst Decision
- CALC Strong Buy
- BATL
- Analyst Count
- CALC 3
- BATL 0
- Target Price
- CALC $16.33
- BATL N/A
- AVG Volume (30 Days)
- CALC 28.4K
- BATL 18.8K
- Earning Date
- CALC 05-20-2025
- BATL 05-19-2025
- Dividend Yield
- CALC N/A
- BATL N/A
- EPS Growth
- CALC N/A
- BATL N/A
- EPS
- CALC N/A
- BATL N/A
- Revenue
- CALC N/A
- BATL $193,893,000.00
- Revenue This Year
- CALC N/A
- BATL N/A
- Revenue Next Year
- CALC N/A
- BATL N/A
- P/E Ratio
- CALC N/A
- BATL N/A
- Revenue Growth
- CALC N/A
- BATL N/A
- 52 Week Low
- CALC $1.43
- BATL $1.05
- 52 Week High
- CALC $6.02
- BATL $6.89
- Technical
- Relative Strength Index (RSI)
- CALC 64.27
- BATL 50.62
- Support Level
- CALC $1.94
- BATL $1.23
- Resistance Level
- CALC $2.15
- BATL $1.38
- Average True Range (ATR)
- CALC 0.13
- BATL 0.10
- MACD
- CALC 0.07
- BATL 0.01
- Stochastic Oscillator
- CALC 80.44
- BATL 49.24
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.